Structure of the autism symptom phenotype: A proposed multidimensional model

BACKGROUND: The main objective of this study was to develop a comprehensive, empirical model that will allow the reorganization of the structure of the pervasive developmental disorder symptom phenotype through factor analysis into more homogeneous dimensions. METHOD: The sample consisted of 209 children with pervasive developmental disorder referred for genetic studies. The 12 subdomains of the Autism Diagnostic Interview-Revised were used in a factor analysis, and the emerged factors were then correlated with independent variables (measures of cognition, adaptive function, and diagnostic subtype). Intraclass correlation coefficients were calculated to investigate any familial relationships between sibling pairs on the derived factors. RESULTS: The autism symptom phenotype is indeed made up of three factors or domains that are somewhat different than those used in DSM-IV. Rather, domains include social-communication, inflexible language and behavior, and repetitive sensory and motor behavior. For the three factors, only a small amount of variance was accounted for by cognitive and adaptive functioning. Only inflexible language and behavior showed familial correlation between siblings. CONCLUSIONS: The pervasive developmental disorder symptom phenotype is composed of three domains or factors: social-communication, inflexible language and behavior, and repetitive sensory and motor behavior. Each child with pervasive developmental disorder can be characterized by these dimensions, which give an informative picture of the clinical presentation and a quantitative estimate of the severity of the disability.     

Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging

PURPOSE: To assess the value of functional magnetic resonance (MR) imaging in the evaluation of early tumor response after transarterial chemoembolization (TACE) for metastatic breast cancer and to compare tumor response based on functional MR imaging versus traditional assessment based on iodized oil deposition, tumor size, and tumor enhancement. MATERIALS AND METHODS: For 14 patients with metastatic breast cancer, MR imaging studies before and after TACE were evaluated. Diffusion and contrast medium-enhanced MR imaging was performed on a 1.5-T unit. Parameters evaluated included change in tumor size, enhancement, and apparent diffusion coefficient (ADC) values. Median survival was also calculated in the entire cohort. RESULTS: A total number of 27 lesions were evaluated, with a mean diameter of 5.5 cm. Although mean tumor size decreased by 18% after treatment, no tumors met the Response Evaluation Criteria In Solid Tumors (RECIST) for complete response (ie, complete disappearance of target lesions) and only seven of 27 met RECIST for partial response (ie, >30% decrease in target lesion size). After treatment, decrease of tumor enhancement in the arterial (32%) and portal venous (39%) phases was statistically significant (P < .0001). Mean tumor ADC increased by 27% (P < .0001) after TACE, whereas ADC remained unchanged in nontumorous liver, spleen, and kidney. Median survival was 25 months for the entire cohort. CONCLUSION: In patients with breast cancer and liver metastases who were treated with TACE, although changes in tumor size were small, significant early changes in the treated lesions occurred on contrast medium-enhanced and functional MR imaging. These include decrease in tumor enhancement and increase in tumor ADC value, which suggest increasing tumor necrosis and cell death.     

Transcatheter arterial chemoembolization: current technique and future promise

Transarterial chemoembolization is the mainstay of catheter based interventional oncologic therapies. This article describes the history of the procedure, selection of appropriate candidates, technical aspects of procedure performance, results, complications, and appropriate follow-up. In addition, the limitations and challenges of the procedure are outlined. Finally, the reader is introduced to novel and promising techniques and devices that hold future promise for transarterial therapy of malignancies.     

Major depressive disorder in adolescence: the role of subthreshold symptoms

OBJECTIVE: To examine the longitudinal association between individual subthreshold symptoms and onset of major depressive disorder (MDD) in adolescence. METHOD: Data for analysis come from the Oregon Adolescent Depression Project, a prospective epidemiological study of psychological disorders among adolescents, ages 14 to 18 years, from the general community. A total of 1,709 adolescents completed the initial diagnostic assessments between 1987 and 1989 (T1) and approximately 1 year later (T2), 1,507 adolescents returned for readministration of assessments (88% response). RESULTS: After controlling for history of depression and gender, seven of the nine DSM-III-R symptoms of depression predicted MDD incidence when tested in separate models. Endorsement of each symptom at T1 increased the likelihood of MDD incidence between T1 and T2. A summary model that included the seven DSM-III-R symptoms as predictors was significant, with sad mood contributing unique variance to the prediction of MDD onset (odds ratio = 2.01). CONCLUSIONS: These findings suggest that much of the variance is shared among symptom predictors and the co-occurrence of symptoms is what constitutes the greatest risk. Moreover, the presence of sad mood contributes additional unique variance to prediction and supports the centrality of depressed mood to MDD.     

Prevalence and Correlates of Physical-mental Multimorbidity in Outpatient Children From a Pediatric Hospital in Canada

ObjectiveThe aim of this study was to estimate the six-month prevalence of mental illness in children with chronic physical illness (multimorbidity), examine agreement between parent and child reports of multimorbidity, and identify factors associated with child multimorbidity.MethodThe sample included 263 children aged 2–16 years with a physician-diagnosed chronic physical illness recruited from the outpatient clinics at a pediatric hospital. Children were categorized by physical illness according to the International Statistical Classification of Diseases and Related Health Problems (ICD)-10. Parent and child-reported six-month mental illness was based on the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID).ResultsOverall, 101 (38%) of children had a parent-reported mental illness; 29 (25%) children self-reported mental illness. There were no differences in prevalence across ICD-10 classifications. Parent-child agreement on the MINI-KID was low (κ = 0.18), ranging from κ = 0.24 for specific phobia to κ = 0.03 for attention-deficit hyperactivity. From logistic regression modeling (odds ratio [OR] and 95% confidence interval), factors associated with multimorbidity were: child age (OR = 1.16 [1.04, 1.31]), male (OR = 3.76 [1.54, 9.22]), ≥$90,000 household income (OR = 2.57 [1.08, 6.22]), parental symptoms of depression (OR = 1.09 [1.03, 1.14]), and child disability (OR = 1.21 [1.13, 1.30]). Similar results were obtained when modeling number of mental illnesses.ConclusionsFindings suggest that six-month multimorbidity is common and similar across different physical illnesses. Level of disability is a robust, potentially modifiable correlate of multimorbidity that can be assessed routinely by health professionals in the pediatric setting to initiate early mental health intervention to reduce the incidence of multimorbidity in children.